( June 10, 2025, 2:36 PM EDT) -- WASHINGTON, D.C. — The government on June 9 waived its right to respond to a petition for a writ of certiorari filed by a stem cell clinic and its owners that argues that the Ninth Circuit U.S. Court of Appeals erred in finding that a stem cell mixture used by clinics is a drug under the federal Food, Drug and Cosmetic Act (FDCA)....